Developmental Research Program

该发展研究计划（DRP）将通过资助莫菲特研究者提出的试点项目，促进转化性皮肤恶性肿瘤研究中创新思想的探索;它不会支持现有完整项目的扩展。弗农·桑达克博士将领导灾难救援队。他是NCI小组委员会G（培训赠款）的成员，也是佛罗里达州颁发的第一个Pre-SPORE补助金的主要研究员。他指导了数十名外科肿瘤学家，被称为杰出的导师。为了最大限度地提高资助项目在需要时能够作为替代项目的可能性，DRP将支持建立新的合作关系，并促进另一个相关领域的有才华的研究者，即皮肤肿瘤学的新研究者，参与皮肤恶性肿瘤研究或促进皮肤恶性肿瘤领域已有研究者的有前途的早期研究。DRP的一个创新特征是，将鼓励研究者提出项目，这些项目虽然位于Moffitt，但可能涉及与另一个Skin SPORE机构的已建立Skin SPORE项目或现有Moffitt Lung SPORE的合作。与Moffitt Lung SPORE合作，每年最多一个DRP奖项将由Skin SPORE作为跨SPORE互动共同支持。鼓励与正在进行的Moffitt Skin SPORE项目相关的DRP项目。DRP将为每年最多三个试点项目提供指导、建议、评估和资金。每个试点项目的目标是在皮肤恶性肿瘤预防、治疗、基础研究或应用研究领域产生足够的高质量数据，以允许向NIH或其他联邦机构提交独立项目，以获得同行评审资金。此外，如果现有的完整项目已完成或未能达到Skin SPORE外部咨询委员会（EAB）与Skin SPORE领导层共同确定的转化目标和预期，则开发项目可作为提升至完整项目状态的潜在替代项目。由奖励评估委员会（AEC）资助的DRP项目的选择将仿照NIH研究部分的审查过程。原子能委员会将由弗农·桑达克博士主持。每个试点项目将有三名审查员，一名主要审查员，一名次要审查员和一名统计审查员。将要求三位评审员使用NIH评分系统为项目分配1.0至9.0的优先级评分。新的皮肤肿瘤学研究者的项目将被给予高度优先考虑。

This Developmental Research Program (DRP) will promote the exploration of innovative ideas in translational cutaneous malignancy research through the funding of pilot projects proposed by Moffitt investigators; it will not support extensions of existing full projects. Dr. Vernon Sondak will lead the DRP. He has been a member of NCI Subcommittee G (training grants) and was the Principal Investigator of the first Pre-SPORE grant awarded by the State of Florida. He has mentored dozens of surgical oncologists and is known as an outstanding mentor. To maximize the likelihood that funded projects will be able to serve as replacement projects if needed, the DRP will support the establishment of new collaborations as well as facilitate either a talented investigator in another relevant field, i.e. a new investigator to cutaneous oncology, to become involved in cutaneous malignancy research or promote promising early research by an investigator already established in the cutaneous malignancy field. An innovative feature of the DRP is that investigators will be encouraged to propose projects that, while based at Moffitt, might involve a collaboration with an established Skin SPORE project at another Skin SPORE institution, or with the existing Moffitt Lung SPORE. In collaboration with the Moffitt Lung SPORE, up to one DRP award per year will be co-supported by the Skin SPORE as a cross-SPORE interaction. DRP projects that link to an ongoing Moffitt Skin SPORE project are encouraged. The DRP will provide guidance, advice, evaluation, and funding for up to three pilot projects per year. The goal for each pilot project is to generate sufficient high-quality data in the field of cutaneous malignancy prevention, treatment, basic research, or applied research to allow for submission of an independent project to the NIH or other federal agency for peer review funding. In addition, developmental projects could serve as potential replacement projects elevated to full project status if an existing full project is completed or fails to meet its translational goals and expectations as determined by the Skin SPORE External Advisory Board (EAB) in conjunction with the leadership of this Skin SPORE. The selection of DRP projects for funding by the Award Evaluation Committee (AEC) will be modeled after the NIH study section review process. The AEC will be chaired Dr. Vernon Sondak. Each pilot project will have three reviewers, a primary reviewer, a secondary reviewer, and a statistical reviewer. The three reviewers will be asked to assign priority scores from 1.0 to 9.0 to the project using the NIH scoring system. Projects from investigators new to cutaneous oncology will be given a high priority.